Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone NeoplasmsGraft vs Host DiseaseBone Marrow CellsWhole-Body IrradiationTransplantation, AutologousLeukemiaAnemia, AplasticTransplantation ConditioningBone and BonesTissue DonorsTransplantation ChimeraHematopoietic Stem Cell TransplantationBusulfanGraft SurvivalHistocompatibility TestingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHistocompatibilityRecurrenceBone Marrow PurgingHematopoietic Stem CellsLeukemia, Myeloid, AcuteCyclophosphamideHematologic NeoplasmsRadiation ChimeraLeukocyte TransfusionPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, IsogeneicImmunosuppressive AgentsGraft vs Host ReactionLymphocyte DepletionRemission InductionGraft vs Tumor EffectMice, Inbred C57BLHematopoiesisAcute DiseaseCombined Modality TherapyImmunosuppressionHepatic Veno-Occlusive DiseaseBone Marrow DiseasesTime FactorsLeukemia, MyeloidLiver TransplantationTreatment OutcomeGraft RejectionLymphocyte TransfusionCytomegalovirus InfectionsT-LymphocytesCyclosporineGraft vs Leukemia EffectChimeraMyelodysplastic SyndromesKidney TransplantationNuclear FamilyBone Marrow ExaminationTransplantation ImmunologySurvival AnalysisBone RemodelingHLA AntigensRetrospective StudiesHematologic DiseasesLymphoma, Non-HodgkinBone Marrow NeoplasmsActuarial AnalysisFatal OutcomeSevere Combined ImmunodeficiencyMice, Inbred BALB CColony-Forming Units AssaySurvival RateImmunocompromised HostStem Cell TransplantationFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsLeukocyte CountSpleenBone DensityDisease-Free SurvivalPancytopeniaCytarabineHeart TransplantationGranulocyte Colony-Stimulating FactorFlow CytometryInfectionCell DifferentiationMultiple MyelomaOpportunistic InfectionsAntilymphocyte SerumLymphomaLeukemia, Myelomonocytic, AcuteMethotrexatePneumonia, ViralGanciclovirBone ResorptionPrognosisLung TransplantationCells, CulturedAntigens, CD34Immunophenotyping